FOLD - AMICUS THERAPEUTICS, INC.
IEX Last Trade
9.81
0.060 0.612%
Share volume: 27,523
Last Updated: Thu 26 Dec 2024 08:29:58 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$9.75
0.06
0.62%
Summary score
7%
Profitability
0%
Dept financing
22%
Liquidity
49%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-28.55%
Return on assets
-5.16%
Return on sales
-53.87%
Return on invested capital
-32.79%
Total debt ratio
73.64%
Debt ratio change over timeo
-3.38%
Current Ratio
3.7%
Quick Ratio
3.49%
Cash Position Ratio
2.82%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-28.28%
Return on assets
-1.96%
Return on sales
-13.94%
Return on invested capital
-26.75%
Total debt ratio
82.15%
Debt ratio change over timeo
-4.31%
Current Ratio
2.84%
Quick Ratio
2.48%
Cash Position Ratio
1.68%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-37.05%
Return on assets
-3%
Return on sales
-19.63%
Return on invested capital
-32.62%
Total debt ratio
81.89%
Debt ratio change over time
-4.08%
Current Ratio
3.03%
Quick Ratio
2.61%
Cash Position Ratio
1.69%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-12.25%
Return on assets
-84.95%
Return on sales
54.15%
Return on invested capital
-2.62%
Total debt ratio
-338.08%
Debt ratio change over time
-3.38%
Current Ratio
-12.54%
Quick Ratio
-11.83%
Cash Position Ratio
-9.66%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FOLD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -28.55% | 13.79% | 34.47% | 7.43% |
| Return on assets | -5.16% | 2.76% | 3.15% | 5.62% |
| Return on sales | -53.87% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -32.79% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 73.64% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -3.38% | 308.97% | -6.99% | 1.18% |
| Dept financing | 20% | 50% | 25% | 7% |
| Current Ratio | 2.84% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.48% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.68% | 0.36% | 1.28% | 2.93% |
| Liquididy | 69% | 13% | 30% | 68% |
| Short-term ratios | FOLD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -28.28% | 13.77% | 13.25% | 3.8% |
| Return on assets | -1.96% | 2.43% | 1.89% | 3.09% |
| Return on sales | -13.94% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -26.75% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 82.15% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -4.31% | 46.38% | -72.08% | 1.51% |
| Dept financing | 22% | 50% | 25% | 7% |
| Current Ratio | 2.84% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.48% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.68% | 0.36% | 1.28% | 2.93% |
| Liquididy | 41% | 12% | 31% | 75% |